Your browser doesn't support javascript.
loading
Distinct mutational pattern of T-cell large granular lymphocyte leukemia combined with pure red cell aplasia: low mutational burden of STAT3.
Park, Sooyong; Yun, Jiwon; Choi, Sung Yoon; Jeong, Dajeong; Gu, Ja-Yoon; Lee, Jee-Soo; Seong, Moon-Woo; Chang, Yoon Hwan; Yun, Hongseok; Kim, Hyun Kyung.
Affiliation
  • Park S; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yun J; Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
  • Choi SY; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Jeong D; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Gu JY; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lee JS; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Seong MW; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Chang YH; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Yun H; Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Kim HK; Department of Genomic Medicine, Seoul National University Hospital, Seoul, Korea. hs.yun@sun.ac.kr.
Sci Rep ; 13(1): 7280, 2023 05 04.
Article in En | MEDLINE | ID: mdl-37142644
T-cell large granular lymphocyte leukemia (T-LGL) is often accompanied by pure red cell aplasia (PRCA). A high depth of next generation sequencing (NGS) was used for detection of the mutational profiles in T-LGL alone (n = 25) and T-LGL combined with PRCA (n = 16). Beside STAT3 mutation (41.5%), the frequently mutated genes included KMT2D (17.1%), TERT (12.2%), SUZ12 (9.8%), BCOR (7.3%), DNMT3A (7.3%), and RUNX1 (7.3%). Mutations of the TERT promoter showed a good response to treatment. 3 of 41 (7.3%) T-LGL patients with diverse gene mutations were revealed as T-LGL combined with myelodysplastic syndrome (MDS) after review of bone marrow slide. T-LGL combined with PRCA showed unique features (low VAF level of STAT3 mutation, low lymphocyte count, old age). Low ANC was detected in a STAT3 mutant with a low level of VAF, suggesting that even the low mutational burden of STAT3 is sufficient for reduction of ANC. In retrospective analysis of 591 patients without T-LGL, one MDS patient with STAT3 mutation was revealed to have subclinical T-LGL. T-LGL combined with PRCA may be classified as unique subtype of T-LGL. High depth NGS can enable sensitive detection of concomitant MDS in T-LGL. Mutation of the TERT promoter may indicate good response to treatment of T-LGL, thus, its addition to an NGS panel may be recommended.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Red-Cell Aplasia, Pure / Leukemia, Large Granular Lymphocytic / Anemia Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Red-Cell Aplasia, Pure / Leukemia, Large Granular Lymphocytic / Anemia Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2023 Document type: Article Country of publication: United kingdom